S
Seer
Diagnostics & Biomarkers
Life sciences company developing proteomics technology platforms to unlock the proteome for biomarker discovery.
Redwood City, CA
Life sciences company developing ultra-sensitive digital immunoassay platforms (Simoa) for biomarker detection.
Diagnostics & Biomarkers
Life sciences company developing proteomics technology platforms to unlock the proteome for biomarker discovery.
Redwood City, CA
Diagnostics & Biomarkers
Life sciences company developing ultra-sensitive proteomics technology (NULISA) for biomarker detection.
Fremont, CA